![FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News](https://news.berkeley.edu/wp-content/uploads/2021/03/Sickle-Cell-750x500-1.jpg)
FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News
![Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - Experimental Hematology Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f2a6d4c2-fd31-4fc9-8501-0a5f95a3027b/fx1.jpg)
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - Experimental Hematology
![PDF] Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. | Semantic Scholar PDF] Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b2af0936c5ca1c3939a3cc0464bb73b9531b5b3a/4-Table2-1.png)
PDF] Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. | Semantic Scholar
![Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research - American Journal of Preventive Medicine Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research - American Journal of Preventive Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9b74dc47-6d12-4554-90ac-bf928bbda3e2/gr1_lrg.jpg)
Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research - American Journal of Preventive Medicine
![UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease | UC San Francisco UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease | UC San Francisco](https://www.ucsf.edu/sites/default/files/styles/article_feature_banner__image/public/2021-03/Sickle-Cell-1920x1000.jpg)